Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q4 2024 Adj EPS $(0.06) Beats $(0.57) Estimate, Sales $10.00K Miss $580.00K Estimate

Author: Benzinga Newsdesk | March 25, 2025 07:03am
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.57) by 89.47 percent. This is a 95.49 percent increase over losses of $(1.33) per share from the same period last year. The company reported quarterly sales of $10.00 thousand which missed the analyst consensus estimate of $580.00 thousand by 98.28 percent. This is a 99.05 percent decrease over sales of $1.05 million the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist